Article • Trisomy 21
Earlier detection of Down’s syndrome
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA.
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA.
Using electrically conductive, ink-like materials, a Swedish consortium has created a fully functional prototype for a self-monitoring blood glucose (SMBG) test that could be disruptive for in vitro diagnostics.
Internet-based training for clinicians could help lower antibiotic prescribing rates for acute respiratory tract infections by as much as 62%, according to British researchers.
Clinical chemistry influences almost all medical disciplines: most diagnoses are made or confirmed only after the laboratory has determined at least one or two parameters.
In intensive care units (ICUs) little can be automated to relieve staff pressures – with the exception of point of care testing (POCT)
Nat Whitney, President of Whitney Research, sums up the ups and downs of the international IVD market and reports on a fitting finale for 17 years of dedicated service
The Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences is designed specifically for clinical sample preparation.
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
Which technological advancements can we expect to see in the field of medical technology? How well can diagnosis and therapy be customized for each patient?
Mass spectrometry has been applied in advanced clinical research and drug discovery and development. Continual innovations have created capabilities to address complex analytical challenges qualitatively and quantitatively with unparalleled speed, sensitivity and accuracy
Labs need to optimise their costs as well as accommodate increasing volumes – and new tests are continuously demanded.
Increasing demand for Point of Care Testing (POCT) devices leads to an increasing number of nurses and physicians working with unfamiliar equipment. Laboratory-quality test results are available in doctor’s surgeries, out-patient clinics and hospital departments. However, how can a high and comparable quality standard for POCT be guaranteed?
Milan, Italy – The 20th European Congress of Clinical Chemistry and Laboratory Medicine certainly lived up to its claim as the EU’s largest event of its kind – 2,407 visitors and 4,786 delegates from 101 countries plus 82 exhibitors fanned out or arranged themselves over the event’s 3,500 square metres, Hanna Politis reports
From the meetings between the Presidents of China and the USA came the slogan, ‘A new model of cooperation’. One item discussed was the proposed $4.6 billion purchase of a US pork producer by a Chinese company, which affirmed: ‘the acquisition won’t affect the quality of the bacon on stateside breakfast tables’.
This year’s EuroMedLab and IFCC-EFLM Congress came at a time when all hospitals face ever-increasing healthcare costs, aging populations and patients and GPs demanding more complex and novel diagnostic tests.
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
If a parameter is determined with different test systems the results must still be comparable. This sounds simple, but is hard to achieve.
The newly relaunched LabsAreVital program will be out in full force at the American Association of Clinical Chemistry (AACC) meeting, from July 28 – August 1 in Houston, Texas.
According to Molly Polen, at the AACC, great opportunities lie ahead for laboratory medicine and, to seize them, ‘meeting with colleagues and learning about new technologies is a critical first step. The 2013 AACC will provide these and other opportunities, such as informative sessions and live demonstrations of new technology.’
EKF Diagnostics has recently marked the production at its manufacturing facility in Barleben, Germany, of the 33,333rd Hemo Control, its globally successful haemoglobin point-of-care analyser, since its launch in 2003.
Evolving technologies and market forces reveal that digital pathology is poised to radically affect the daily workflow and activities of pathologists and diagnostic laboratories
Managing physicians’ test requests is a key ingredient of modern lab management. However, doctors and nurses still do not provide the clinical reasons for orders to all labs.
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
Snibe, Shenzhen New Industries Biomedical Engineering Co., Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and reagents.